Business Wire

  1. Summit Health Announces Internalization Of Genomic Testing Cooperative State-Of-The-Art Next Generation Sequencing DNA And RNA Profiling Tests For Tissue And Liquid Biopsy Of Solid Tumors And Hematologic Neoplasms 5/20/2025

    Summit Health, part of Village MD and Genomic Testing Cooperative (GTC), the global leader in RNA innovation, are excited to announce today the launch of a newly established next generation sequencing service at the Summit Health laboratory in Woodland Park, NJ to offer comprehensive DNA and RNA profiling of solid tumors and hematologic neoplasms.

  2. Revvity's EUROIMMUN Unveils New Fully Automated Instrument For Specialty Testing 5/19/2025

    Revvity, Inc today announced the launch of its new IDS i20 analytical random access platform from EUROIMMUN, enabling full automation of chemiluminescence immunoassays (ChLIA).

  3. Prevencio Receives FDA Breakthrough Device Designation For HART CADhs, Its Artificial Intelligence-Driven Blood Test For Obstructive Coronary Artery Disease 5/13/2025

    Prevencio, Inc., the leader in artificial intelligence-powered blood tests for cardiovascular diagnostics, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its HART CADhs test.

  4. Countable Labs Launches Category-Defining, Highly Sensitive PCR Platform — Countable PCR — Finally Quantifying Rare Events, Even From Limited Samples 5/13/2025

    Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection.

  5. QIAGEN Enhances Leading Clinical Genomics Portfolio With Acquisition Of Genoox AI-Powered Software 5/12/2025

    QIAGEN today announced it has signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.

  6. OmniAb Introduces The xPloration Partner Access Program 5/8/2025

    OmniAb, Inc. today introduced the launch of the xPloration Partner Access Program, under which current OmniAb partners can purchase the xPloration instrument to significantly enhance their capabilities in antibody discovery and development.

  7. New Inverted Light-Sheet Microscopy Platform For Research And Clinical Applications 5/6/2025

    ZEISS and Alpenglow Biosciences today announced a new partnership to jointly develop an inverted light-sheet microscope and bioinformatics pipeline tailored specifically for clinical applications. Alpenglow, a pioneering 3D spatial biology company specializing in open-top light-sheet microscopy, data processing, and AI-driven analysis for biopharma and clinical applications, has partnered with ZEISS, a global leader in light-sheet imaging technologies and visualization software – including ZEISS Lattice Lightsheet 7 and arivis software.

  8. StatLab Activates New U.S. Manufacturing Capabilities To Secure Supply For Domestic Pathology Labs 5/1/2025

    StatLab Medical Products (“StatLab”), a leading global innovator of pathology supplies, today announced the launch of new U.S.-based manufacturing capabilities, advancing its multi-year "in-region, for-region" strategy to ensure reliable, scalable production of critical reagents for pathology labs nationwide.

  9. Predicta Biosciences Launches Its First Molecular Diagnostic Product To Improve The Prognosis Of Multiple Myeloma 4/30/2025

    Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory Developed Test (LDT): GenoPredicta for bone marrow or blood.

  10. Promega ProDx MSI Detection Kit Receives NMPA Innovative Medical Device Registration Certificate In China 4/29/2025

    Promega announced that the ProDx MSI Detection Kit has been awarded an innovative medical device registration certificate from the National Medical Products Administration (NMPA) in China.